Kisspeptin shots for low hormone condition
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests if a hormone called kisspeptin can help people with a condition that limits sex hormones. The trial involves regular shots under the skin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a condition called IHH (idiopathic hypogonadotropic hypogonadism), which means your body doesn't make enough sex hormones.
- Your diagnosis has been confirmed by a doctor and tests show low sex hormones along with low or normal other signals.
- Your blood pressure is normal (systolic under 140 and diastolic under 90).
- You are not currently using medications that affect hormones, or you are willing to stop them for a while before starting the study.
- If you can become pregnant, you agree to use birth control during the study and for a month after the last kisspeptin shot.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if kisspeptin injections can help women with hypothalamic amenorrhea (a pause in periods due to stress, low weight, or too much exercise). The goal is to see if it can restart the reproductive system naturally.
This study tests how the brain's reproductive hormone system works after a COVID-19 infection using a substance called kisspeptin. It may help explain symptoms like changes in periods or hormone levels in people with long COVID.
This study gives the hormone kisspeptin over time and measures how your body’s reproductive hormones respond. It may help researchers understand how reproductive hormone signals work, which could guide future treatments.
This trial tests an experimental medicine for teenage boys with a condition called hypogonadotropic hypogonadism, where the body doesn't make enough sex hormones. The treatment combines two hormone-based injections to help the testes grow and function, with a goal of improving puberty.
This study tests a new medicine called HHK001 for endometriosis. It is compared with a standard treatment (Enantone) to see if it is safe and works well to reduce symptoms.
This study tests an experimental injection (HHK001) compared to a standard hormone-blocking medicine (Enantone) for women with endometriosis. The goal is to see if the new injection is safe, how it works in the body, and if it helps with endometriosis symptoms.
Hear when a new Hypogonadotropic Hypogonadism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.